Skip to main content

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about board meeting

19 Jan 2017 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on February 11, 2017, to consider and approve Un-Audited Financial Results for the quarter and nine months ended December 31, 2016 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..